NCT02248181View on ClinicalTrials.gov

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

442

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2005

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02248181 - Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease | Biotech Hunter | Biotech Hunter